A Study on Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors As Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. AJP 2018, 12 (03). https://doi.org/10.22377/ajp.v12i03.2625.